Brief: Isofol Medical Q3 Loss For Period Widens To SEK 10.9 Mln
Nov 12 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* Q3 RESULT FOR PERIOD AMOUNTED TO KSEK -10,859 (-6,245)
* Q3 NET REVENUE AMOUNTED TO KSEK 0 (0)
Source text: ID:nMFN2DQ1Rm
Further company coverage: ISOFOL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million
Brief: Isofol Medical Announces Bfarm Approval Of Optimized Phase Ib/Ii Study Design
Brief: Isofol Gets Gross Proceeds Of SEK 18.9 Mln In Connection With Exercise Of Warrants And Guarantee Commitments
Brief: Isofol Secures License Rights For Arfolitixorin In Autism